Júlia Solana Balaguer, PhD’s Post

Early detection is critical

We're glad to see the recommended age for mammograms is back to age 40 for those with average risk in the recent guidelines by the U.S. Preventive Services Task Force, however we believe there's more to be done. We need annual screenings instead of every other year, more proactive options for younger people at higher-risk, routine discussions about breast cancer risk with doctors starting at age 30, and specialized imaging for those with dense breast tissue. Get the facts about mammograms at https://bit.ly/3UH9lzh

Science News from research organizations False-positive mammograms discourage some women from future screenings New study says false positives are all the more reason to keep on schedule with mammograms Date: September 2, 2024 Source: University of California - Davis Health Early detection of breast cancer through mammography screening continues to save lives. However, abnormal findings on mammograms can lead to women being recalled for additional imaging and biopsies, many of which turn out to be "false positives," meaning they do not result in a cancer diagnosis. False positives can also have financial implications for patients and cause significant emotional anxiety. A major, new study led by the UC Davis Comprehensive Cancer Center has found that women who received a false-positive result that required additional imaging or biopsy were less likely to return for that follow-up screening. https://lnkd.in/gatVWcdN

The role of screening mammography in the reduction of mortality due to breast cancer is undeniable. Most DCIS cases are detected during a screening mammography! It’s important to know your personal risk and make a screening plan that works for you!

🎗 𝐎𝐜𝐭𝐨𝐛𝐞𝐫: 𝐁𝐫𝐞𝐚𝐬𝐭 𝐂𝐚𝐧𝐜𝐞𝐫 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐌𝐨𝐧𝐭𝐡 🎗 ⚕ Breast cancer continues to be the most prevalent cancer among women, with over 2.3 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐧𝐞𝐰 𝐜𝐚𝐬𝐞𝐬 diagnosed globally in 2022. Only 𝐈𝐧 𝐈𝐭𝐚𝐥𝐲 alone, more than 55,000 𝐧𝐞𝐰 𝐜𝐚𝐬𝐞𝐬 were reported last year. Unfortunately, up to 40% of patients who undergo breast cancer surgery require a second operation due to positive margins detected after the first procedure. 𝐊𝐞𝐲 𝐃𝐚𝐭𝐚: ✅ Global number of surgeries for tumor removal: 19.3 million new cancer cases were recorded in 2020, and 80% of these required surgical intervention https://lnkd.in/e46u-Bbe ✅ In Italy, over 55,000 new cases of breast cancer were diagnosed in 2022https://lnkd.in/eGxRr8dE World Health Organization (WHO) https://lnkd.in/eT2hkdwe ✅ The percentage of patients who require a second surgery due to positive margins ranges between 20% and 40% https://lnkd.in/eWykerf2 https://lnkd.in/e-Bin2ec ✅ Average time between the first and second surgeries: typically from a few days to several weeks, depending on the time needed for histopathological analysis https://lnkd.in/eGxRr8dE ✅ Market growth in oncological surgery: projected to grow at a 7% CAGR over the next 5-7 years, driven by rising diagnoses and technological advancements. https://lnkd.in/einesPdv FAINOVA Sagl is collaborating with the Dipartimento Biotecnologie Molecolari e Scienze per la Salute to develop an innovative project aimed at significantly reducing reoperation rates by improving intraoperative margin assessment. This new technology will enable real-time analysis during surgery, enhancing outcomes for thousands of patients. For further information, visit the official IARC link: https://lnkd.in/eyCyf9yG 💖Join me in spreading awareness and advocating for improved breast cancer prevention and care 💖 #BreastCancerAwareness #Innovation #Healthcare #Prevention #R&D #Oncology #Technology #MedTech

According to a new Canadian study, some women with early-stage #cervicalcancer can be safely treated with a less-invasive #hysterectomy that has fewer complications. The current standard treatment for early-stage cervix cancer is a radical hysterectomy, removing not only the uterus and cervix, but also the surrounding tissue and up to one-third of the vagina. Alternatively, the researchers found that women who had a simple hysterectomy (a less-invasive procedure wherein the surrounding tissue and most of the vagina remain intact) were at no higher risk of #cancer recurring in the pelvic area after three years than those who had a radical hysterectomy. Also, women who underwent a radical hysterectomy were more likely to have #urinaryincontinence (loss of bladder control) and sexual side-effects after surgery. However, the simple hysterectomy should only be an option for cervical cancer patients who have early-stage disease, with superficial lesions less than or equal to 2 centimeters and do not have lymph node involvement. There has been a gradual trend whereby physicians have started to suggest less radical surgery is sufficient for these select patients and the results of this study further substantiate that less-invasive surgery is also a safe option for patients. 🌟 Join the fight against women's cancers. Donate to WCRF today and help us make groundbreaking advancements in cancer research. Every contribution counts. 💪 [Link in bio] https://lnkd.in/e-wm3RcX #SupportWCRF #DonateNow #cancerresearch

Dr. Scot Ackerman joined the WJXT- News4Jax team to discuss the crucial role of early detection in combating breast cancer. Dr. Ackerman acknowledged the concerning trend of a rise in breast cancer diagnoses among women in their 40s and early 50s over the past 15 years, prompting a re-evaluation of screening guidelines.⁠ 📺️⁠ Highlighting the significance of starting mammograms at age 40, Dr. Ackerman emphasized the potential to reduce breast cancer deaths by up to 20% in this age group. Advanced screening methods like 3D mammograms and contrast-enhanced mammograms offer high-resolution imaging, crucial for detecting cancer at its earliest stages.⁠ 📺️⁠ Read more on our blog and watch the entire segment. ⁠ #BreastCancerAwareness #EarlyDetection #Mammograms #AckermanCancerCenter

🔦 #EuraSpotlight on Breast Cancer Imaging 🔦 #BreastCancer remains the most commonly diagnosed #cancer among #women, making effective screening and diagnostic approaches critical. This edition of #EuraSpotlight focuses on two fundamental articles from the ESR Essentials series, offering valuable insights into both screening and diagnostic protocols for breast cancer. --------------------------- 📄 Screening for Breast Cancer: General Recommendations by the European Society of Breast Imaging (EUSOBI) Authored by Magda Marcon, Michael H. Fuchsjäger, Paola Clauser & Ritse M. Mann, this article delves into the evolving landscape of breast cancer screening. It highlights the enduring role of mammography, the importance of MRI for high-risk women, and the potential of #AI in refining risk categorization. The move towards personalized screening approaches is emphasized, underscoring the need for shared decision-making between patients and physicians. Read the full article here: https://buff.ly/3WCVIT2 --------------------------- 📄 Diagnostic Work-up in Patients with Symptomatic Breast Disease—Practice Recommendations by EUSOBI In this article, Alexandra Athanasiou, Linda Appelman, Ruud M. Pijnappel, Fiona J. Gilbert, Federica Pediconi, & Ritse Mann provide crucial guidelines for diagnosing symptomatic breast disease. The recommendations cover the appropriate use of ultrasound, digital breast tomosynthesis, and mammography, tailored to patient age and specific symptoms. It also stresses the importance of avoiding unnecessary biopsies while ensuring that malignancies are not missed. Read the full article here: https://buff.ly/3YYZSWv --------------------------- 🙋 Stay informed with these key articles and ensure you’re up-to-date with the best practices in breast cancer imaging! #BreastCancer #EuropeanRadiology #ESREssentials

What is breast cancer? | program #Emirates_Morning. Breast cancer is a disease in which abnormal breast cells grow out of control and form tumours. If left unchecked, the tumours can spread throughout the body and become fatal. Breast cancer cells begin inside the milk ducts and/or the milk-producing lobules of the breast. The earliest form (in situ) is not life-threatening and can be detected in early stages. Cancer cells can spread into nearby breast tissue (invasion). This creates tumours that cause lumps or thickening.  Invasive cancers can spread to nearby lymph nodes or other organs (metastasize). Metastasis can be life-threatening and fatal. Treatment is based on the person, the type of cancer and its spread. Treatment combines surgery, radiation therapy and medications. Scope of the problem In 2022, there were 2.3 million women diagnosed with breast cancer and 670 000 deaths globally. #BreastCancer occurs in every country of the world in women at any age after puberty but with increasing rates in later life.  Global estimates reveal striking inequities in the breast cancer burden according to human development. For instance, in countries with a very high Human Development Index (HDI), 1 in 12 women will be diagnosed with breast cancer in their lifetime and 1 in 71 women die of it. In contrast, in countries with a low HDI; while only 1 in 27 women is diagnosed with breast cancer in their lifetime, 1 in 48 women will die from it.

Olivia Munn has highlighted a significant limitation of breast cancer screening: mammography is not a one-size-fits-all solution. This article excellently articulates the importance of every woman understanding her risk for breast cancer through a multifaceted approach.  - Breast Cancer Risk Assessment - Appropriate screening (mammogram, breast ultrasound, breast MRI) at the appropriate time - Genetic Testing if needed - Clinical Breast Exams with your healthcare provider - Self-breast awareness, knowing how your breasts look and feel While mammograms are considered the standard of care for detecting breast cancer, and likely are not going anywhere anytime soon (mammograms detect microcalcifications, tiny calcium deposits in the breast that may be an early sign of abnormal cell growth, better than a breast ultrasound or a breast MRI) they may not be an effective screening exam for all women. Even within mammography, there are options. Young women, and women with dense breast tissue (nearly 50% of all women over the age of 40 have dense breast tissue), should ask their providers about 3D mammograms which have been shown to increase the cancer detection rate in certain cases. They should also ask about adjunct screening exams with breast ultrasound or breast MRI along with their annual mammograms. To learn about your breast cancer risk and what steps you should be taking, check out Gabbi's risk assessment and telehealth care. https://lnkd.in/guagW-Zb #womenshealth #breastcancer #breastcancerdiagnosis #preventativehealth